Sciencepulse

The Scientist Who Decoded the Gut Hormone Behind Weight-Loss Jabs

Health Science·October 26, 2026

The Scientist Who Decoded the Gut Hormone Behind Weight-Loss Jabs

A few years ago, a self-injected drug that produces meaningful weight loss would have sounded like science fiction. Today, medicines in the GLP-1 class are a global phenomenon, widely used to treat obesity and type 2 diabetes and often described as near-miracle drugs. The drugs work by copying a gut hormone of the same name, which signals to the brain that you have eaten enough and prompts the pancreas to release insulin.

The hormone's story is closely tied to Jens Juul Holst, a professor of medical physiology and biomedical sciences at the University of Copenhagen. According to the programme notes, years of his work went into discovering and decoding GLP-1, and that foundation is what made the current generation of treatments possible. His research has earned him a long list of high-profile honours.

In an episode of The Life Scientific, the long-running interview series, Holst spoke with presenter Jim Al-Khalili. The conversation was not simply a celebration. Holst addressed the questions that tend to follow a runaway success: side effects, the tendency of many patients to regain weight once treatment stops, a black market in unlicensed versions of the drugs, and the cost that keeps many people from getting them at all.

The discussion also looked beyond weight and blood sugar. The episode summary notes that these medicines may have effects on other health conditions, and that research into those possibilities is ongoing. Holst shared his hopes for where GLP-1 research goes next, a question that matters as much to patients waiting for affordable access as it does to scientists.

Reporting based on an external source.